{"url":"https://lda.senate.gov/api/v1/filings/e97ff2b5-c72a-4bb2-8f5a-05c882eeec59/","filing_uuid":"e97ff2b5-c72a-4bb2-8f5a-05c882eeec59","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2024,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/e97ff2b5-c72a-4bb2-8f5a-05c882eeec59/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jill Rathbun, Managing Partner - Galileo Consulting Group","dt_posted":"2024-07-19T00:02:13-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"624 South Highland Street","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22204","registrant":{"id":40021155,"url":"https://lda.senate.gov/api/v1/registrants/40021155/","house_registrant_id":39819,"name":"GALILEO CONSULTING GROUP, INC.","description":"Life sciences and health care consulting.","address_1":"624 South Highland Street","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22204","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JILL RATHBUN","contact_telephone":"+1 703-217-7224","dt_updated":"2026-07-27T17:48:39.761024-04:00"},"client":{"id":187981,"url":"https://lda.senate.gov/api/v1/clients/187981/","client_id":202,"name":"AIQ SOLUTIONS","general_description":"Developer of medical device technology platform","client_government_entity":false,"client_self_select":null,"state":"WI","state_display":"Wisconsin","country":"US","country_display":"United States of America","ppb_state":"WI","ppb_state_display":"Wisconsin","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-08-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"FY2024 Continuing Appropriations and Other Extensions Act (through 11/17/2023) H.R. 5860; SBIR Funding and grant support for National Institutes of Health/National Cancer Institute submissions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":38997,"prefix":null,"prefix_display":null,"first_name":"JILL","nickname":null,"middle_name":null,"last_name":"RATHBUN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to Medicare reimbursement for AI enabled treatment response procedures - Meetings with House and Senate Offices regarding a predictable and dependable Medicare reimbursement pathway for Software as a Service procedures or procedures that provide clinicians with additional information that is produced with AI enabled software .","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":38997,"prefix":null,"prefix_display":null,"first_name":"JILL","nickname":null,"middle_name":null,"last_name":"RATHBUN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}